# US 2026/0144914 A1 · Minimally invasive methods for plastic and aesthetic facial restoration using bone derived compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0144914 A1
- Document ID: US20260144914A1
- Status: Published application
- Kind: A1
- Application number: 19/402,447
- Filed: 2025-11-26
- Published: 2026-05-28
- Earliest claimed: 2024-11-27
- Assignees: Musculoskeletal Transplant Foundation
- Applicants: Musculoskeletal Transplant Foundation
- Inventors: Marc LONG
- Web page: https://patentgrep.com/patent/US20260144914A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 24/0036: {Porous materials, e.g. foams or sponges}
- A61L 24/0089: {containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084}
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3612: {Cartilage, synovial fluid}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/3847: {Bones}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/406: Antibiotics
- A61L 2300/414: Growth factors
- A61L 2300/42: Anti-thrombotic agents, anticoagulants, anti-platelet agents
- A61L 2300/626: Liposomes, micelles, vesicles
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/40: Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Methods are provided for aesthetic restoration and reconstruction of bone loss, deficit, defect, or a combination thereof. The methods include administration of one or more suitable bone derived compositions by a minimally invasive procedure such as injection using a needle, syringe, etc., placement in or through a small incision, or a combination thereof. The properties and characteristics of the bone derived composition, including without limitation, flowability, injectability, size, shape, and physical form, are limited only by the requirement that they are capable of administration by a minimally invasive technique. For example, these methods are effective for restoration of facial features, e.g., lost chin definition, jawline definition, bone around nasal lines, and bone around the upper and lower eye area. These methods are also effective for treatment of bone deficiency and loss in other body features such as shoulders and collarbones, pelvis, feet, ankles, hands, and wrists.

## Claims

### Claim 1

A method for treatment of a body feature having a condition comprising one or more of bone loss, bone deficit, and bone defect, the method comprising the steps of:
selecting and obtaining one or more bone derived compositions; and
administering the one or more bone derived compositions to a treatment site which is on, in, proximate to, or a combination thereof, the body feature.

### Claim 2 (depends on 1)

The method of claim 1, wherein the treatment comprises restoration, reconstruction, volumizing, or both, of one or more of: a size, a shape, a contour, and a volume, of the body feature being treated.

### Claim 3 (depends on 1)

The method of claim 1, wherein the step of administering comprises one or more of: implanting, injecting, positioning, reshaping followed by administering, the one or more bone derived compositions to the treatment site, by a minimally invasive procedure.

### Claim 4 (depends on 3)

The method of claim 3, wherein the minimally invasive procedure comprises injection using a delivery device, delivery in or through a small incision, or a combination thereof.

### Claim 5 (depends on 4)

The method of claim 4, wherein the minimally invasive procedure comprises injection using a delivery device selected from a needle, a syringe, and a cannula, and having a gauge number of about 20 or lower.

### Claim 6 (depends on 4)

The method of claim 4, wherein the minimally invasive procedure comprises delivery in or through a small incision having a length from about 1 centimeter to about 0.5 millimeter.

### Claim 7 (depends on 1)

The method of claim 1, wherein the one or more bone derived compositions comprise a physical form including: particles, powder, pieces, fibers, at least partially dehydrated, non-dehydrated, flowable, injectable, shapable, at least partially solidifying, preshaped, molded, porous, a paste, a putty, a gel, a suspension, a mixture, a monolithic piece, a mass of smaller forms agglomerated together into a single piece, and combinations thereof.

### Claim 8 (depends on 7)

The method of claim 7, wherein the one or more bone derived compositions comprise bone derived fibers.

### Claim 9 (depends on 7)

The method of claim 7, wherein the one or more bone derived compositions comprise a demineralized bone matrix (DBM) and are flowable and injectable.

### Claim 10 (depends on 9)

The method of claim 9, wherein the one or more bone derived compositions comprise bone derived fibers in a flowable, injectable, composition which further comprises a viscosity modifier comprising hyaluronic acid, derivatives of hyaluronic acid, or both.

### Claim 11 (depends on 7)

The method of claim 7, wherein the physical form of the one or more bone derived compositions comprises a monolithic piece, a mass of smaller physical forms agglomerated together into a single piece, or a combination thereof, which has an overall size and shape selected and formed, molded, at least partially solidified, or otherwise produced to be specific to the treatment site or body feature being treated.

### Claim 12 (depends on 7)

The method of claim 7, wherein the physical form of the one or more bone derived compositions comprises a porous matrix.

### Claim 13 (depends on 1)

The method of claim 1, wherein the one or more bone derived compositions includes one or more properties selected from: containing viable cells, absence of viable cells, containing non-viable cells and cell components, demineralized, partially demineralized, selectively demineralized, non-demineralized, porous, containing one or more endogenous bioactive materials, containing one or more exogenous materials and substances which are bioactive or not.

### Claim 14 (depends on 13)

The method of claim 13, wherein the one or more endogenous bioactive materials are selected from: proteins, growth factors, cytokines, vesicles, exosomes, extracellular matrix proteins, cells and cellular components.

### Claim 15 (depends on 13)

The method of claim 13, wherein the one or more exogenous materials and substances are selected from: cells, polymers, carriers, excipients, fillers, viscosity modifiers, antibiotics, anticoagulants, and binders.

### Claim 16 (depends on 1)

The method of claim 1, wherein the one or more bone derived compositions are combined with other materials and compositions, which are: tissue derived, not tissue derived, endogenous, exogenous, bioactive, inert, natural, synthetic, and combinations thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein the tissue derived materials comprise: cartilage derived materials, placenta derived materials, or a combination thereof.

### Claim 18 (depends on 1)

The method of claim 1, wherein the body feature comprises one or more of: a facial feature, a skull, a shoulder, a collarbone, a pelvis, a long bone, a foot, an ankle, a hand, and a wrist.

### Claim 19 (depends on 1)

The method of claim 1, wherein the body feature comprises a facial feature which comprises: a jawline, a chin, a brow bone, a cheekbone, a malar area, a bone proximate nasal lines, a bone proximate upper eye area, a bone proximate lower eye area, or a combination thereof.
